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It has been a real pleasure to have worked with Professor Bernard Gerstman of the Department
of Physics at the Florida International University on this special issue of The Physics of Cancer for
AIP Advances.
Two questions probably spring to mind for the prospective reader of this issue: “why cancer,
and why physics?” Let’s tackle the “why cancer?” first. If cancer was just another one of the many
diseases afflicting mankind it would of course be worthy of study but no more so than other diseases.
However, there seems to be something quite special about cancer that makes it of intense scientific
interest. That special thing is that we do not understand cancer well enough to have more than the
flimsiest means of controlling it, let alone actually decreasing the mortality rate due to cancer. Figure 1
taken from the National Cancer Institute is an example of the rather grim picture in spite of many
billions of dollars spent on cancer: the age-adjusted mortality rate is essentially flat over the past 40
years.
There are two basic reasons why the mortality rate is flat: (1) cancer tumors typically evolve
resistance to various attempts to kill them, over a period of months to years. Once this resistance has
evolved, the procedure designed to kill the growing cancer cells has to be changed and that is often a
futile process. The evolution of resistance is basically a Darwinian process of natural selection, but
in a very complex environment, and it may not be strictly genomic. (2) Most tumors if they were
to stay in one place are survivable. Unfortunately, quite often they metastasize, that is, the cancer
cells undergo an phenotype switch and become invasive, spreading to other quite specific parts of
the body, depending on the tumor. If the metastasis is connected with the evolution of resistance
to chemotherapy it is basically a one-way street to death of the patient. Metastasis can be seen
as a change in the strategy of the tumor from being indolent, or slowly growing in one place, to
an aggressive invasion of new territory. Thus, the “why cancer” question can be summed up by
saying that cancer seems to be an uniquely unsolved problem in biology indicating that there are
fundamental aspects of multicellular dynamics which we simply do not understand at present.
“Why physics?” I have been claiming (I am hardly the only one of course) for a few years
that physics has to expand its horizons to accept the fact that biology may represent an intellectual
challenge every bit as worthy as our attempts to find the Higgs boson, or grasp the emergence
of collective phenomena in condensed matter systems, or understand the dynamics of quantum
mechanics in atomic systems. It is possible that there remain truly deep mysteries in biology that we
have not yet formulated from a physics perspective, but which may yield to the ideas in physics that
have been so successful. The fact that we really have been stymied in dealing with cancer means to
me that conceptually we really are facing a deep mystery.
Of course, beyond the pure intellectual challenge of cancer there is the technological aspect of
physics that can be applied to cancer treatment. Physicists have made extraordinary contributions
to biology over the past 100 years that have transformed the field. One need only stroll around the
area surrounding Kendall T Station in Cambridge Massachusetts, past the Whitehead Institute and
the Broad Institute, to be astonished by how biology has become an extraordinarily high-technology
discipline. But we can’t stop with genome sequencing; there are far deeper problems in cancer that
will hopefully yield to new technologies that are still in the formative stages. Another aspect of
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FIG. 1. (A) Rates of cancer diagnosis per 100,000 males versus time. (B) Age-adjusted deaths/100,000 people versus time.
physics which has not fully moved into the cancer world is the highly quantitive and predictive
growth of our ability to create sophisticated models to understand the growth and dynamics of
mutating cancer cells under stress, both mechanical and metabolic. Although the challenges are
great, in principle modeling could be used in the future to do personalized treatment of cancers
coupled with the development of high technologies.
I am happy to say that the 16+1 papers Prof. Gerstman and I have selected for this special issue
span the challenging range of issues I have discussed above. Let’s start at the top: The Big Issues of
really rethinking cancer from a physics perspective and asking what new ideas we may need. The
furthest one out there is clearly the article by Davies et al.,1 “Implications of quantum metabolism
and natural selection for the origin of cancer cells and tumor progression”. I may not agree with
many of the things posited in this paper, but I would have been very disappointed if we didn’t have
at least one paper which challenges us at a fundamental level. Another challenging paper that looks
at the origins of cancer is the one by Soto-Ortiz and Brody,2 “A theory of the cancer age-specific
incidence data based on extreme value distributions”, which questions the usual assumptions that
cancer is due to the accumulations of “mistakes” in a random manner.
Less controversial but equally exciting are the papers by Chignola and Milotti3 (“Bridging the
gap between the micro- and the macro-world of tumors”) and Jiao and Torquato4 (“Diversity of
dynamics and morphologies of invasive solid tumors”) which attempt to understand the dynamics
of an invading population of a mutating cells, while Chauviere et al.5 uses the powerful ideas
coming out of density functional theory (“Dynamic density functional theory of solid tumor growth:
Preliminary models”) to see if ideas which really first came out of quantum mechanics can be
applied to tumor dynamics. Jia and Torquato4 in their analysis bridge the gap between the genomic
evolution occurring and the physical forces that are exerted on the tumor, a topic taken up in more
detail by Gillies6 (“Some observations on the mechanics and dynamics of tumor heterogeneity”)
and Pokorny´7 (“Physical aspects of biological activity and cancer”). Our own paper with Chris
Cleveland8 on “Physics of cancer propagation: a game theory perspective” tries to look at cancer
invasion from a game theoretic perspective as opposed to a strictly physical one. Our paper brings
up the subject of information transfer in cancer, and this is explored by Laise et al.9 (“Modeling
TGF-β signaling pathway in epithelial-mesenchymal transition”).
In the more applied area of cancer therapeutics there are some very original papers debuting
here. For example, there is the time axis: can modulations in the time of dosage alter the way
that the tumor responds, and what role does the immune system dynamics play a role in cancer
growth and development? These issues are addressed by Portz et al.10 (“A clinical data validated
mathematical model of prostate cancer growth under intermittent androgen suppression therapy”),
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Cerofolini11 (“Host-guest interaction in cancer and a reason for the poor efficiency of the immune
system in its detection and termination”) and Wiley and Haraldsen12 (“The theory of modulated
hormone therapy for the treatment of breast cancer in pre- and post-menopausal women”). The
development of new technologies, such as laser driven ultra-fast high energy proton therapy by
Doria et al.13 (“Biological effectiveness on live cells of laser driven protons at dose rates exceeding
109 Gy/s”), Alfano14 explores using ultra-fast lasers to diagnose metastatic cancer cells (“Advances
in ultrafast time resolved fluorescence physics for cancer detection in optical biopsy”) while Solano
et al.15 explore photo-acoustic imaging (“An experimental and theoretical approach to the study
of the photoacoustic signal produced by cancer cells”). I was intrigued by the paper of Frieboes
et al.16 which is a combination of sophisticated modeling of drug delivery to tumors coupled with
new imaging technologies which will allow us to optimize modeling of drug delivery based upon
observations. Bichsel’s paper on “Statistics of cell dose and cell survival in C-ion therapy” was a bit
late for the special issue but will hopefully appear in a subsequent issue of AIP Advances, that is the
“+1” of the 16+1 papers we have selected.
This brings up something I hope will change in AIP Advances. As I said, I (along with others) feel
that physics has to expand its horizons, to accept the fact that biology may represent a fundamental
intellectual challenge to “hard” science. I hope that this Special Issue on the Physics of Cancer marks
the start of a tradition of excellent biological physics papers in AIP Advances.
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